Searched for
INDIA PHARMA LOBBY GROUPS
India convenes third preparatory meet of BRICS Women's Working GroupIndia, under its BRICS Chairship, hosted the third preparatory meeting for the BRICS Women's Working Group virtually. Discussions centered ...- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Austria lobbies EU to host Anthropic AI after US curbs: ReportAustria is pushing the European Union to consider hosting Anthropic AI system within its borders to counter efforts by the U.S. to bloc...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Apple seeks US approval to buy chips from blacklisted Chinese companyReports suggest that Apple is actively reaching out to the Trump administration in an effort to source memory chips from ChangXin Memory Te...
- Mumbai's faith, food and identity: The battle over sacred traditionsThe evolution of Mumbai from seven islands into a bustling urban center illustrates the ongoing tension between age-old traditions and cont...
- How Tour Times is redefining organised group travel in IndiaIndia's domestic tourism is booming, with organized group travel, especially religious pilgrimages and corporate events, leading the charge...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- RICE Adamas Group expands national footprint with Mumbai Office inaugurationAdamas University and Adamas Tech Consulting have launched a new Mumbai office and the Adamas School of Experiential Learning, offering 10-...
- Alibaba sues Pentagon over blacklist designationAlibaba Group on Tuesday filed a federal lawsuit challenging the US Defense Department's designation of the Chinese technology giant as a "...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Telegram CEO claims Reliance, WhatsApp's role behind efforts to ban company's app in IndiaTelegram CEO Pavel Durov accuses Reliance Group and WhatsApp of lobbying to ban his app in India. He also claims Reliance is disrupting Tel...
Load More
